Opportunity Information: Apply for CDC RFA PS08 8020401SUPP11
Apply for CDC RFA PS08 8020401SUPP11
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "HIV/AIDS Surveillance" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.944 Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance.
- This funding opportunity was created on May 31, 2011 and posted on May 6, 2011.
- Applicants must submit their applications by Jun 20, 2011. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $17,700,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $400,000.00 in funding.
- The number of recipients for this funding is limited to 65 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Part I Core Surveillance has been limited to state health departments, the six independently funded local health departments (Chicago, Houston, Los Angeles, New York City, the City of Philadelphia and San Francisco),the District of Columbia, and the territorial health departments (Commonwealth of Puerto Rico, the U.S Virgin Islands). Part II Core Surveillance in the Pacific Islands jurisdictions has been limited to American Samoa, Guam, Marshall Islands, Palau, the Commonwealth of the Northern Mariana Islands and the Federated States of Micronesia. Applicants eligible to apply for this cooperative agreement are limited to existing grantees under FOA PS08 802 HIV/AIDS Surveillance, Parts I Core Surveillance and Part II Core Surveillance in the Pacific Islands. Eligible applicants are state health departments, which includes the six independently funded local health departments (Chicago, Houston, Los Angeles, New York City, the City of Philadelphia and San Francisco), the District of Columbia, the territorial health departments (Commonwealth of Puerto Rico, the U.S Virgin Islands) and the Pacific Islands American Samoa, Guam, Marshall Islands, Palau, the Commonwealth of the Northern Mariana Islands and the Federated States of Micronesia. Competition is limited to existing grantees under PS08 802 to ensure that the HIV/AIDS surveillance system covers the entire United States and its territories. The eligible health departments have jurisdiction over promulgating laws and legislations over specific states and metropolitan areas. Only entities that are legislatively charged to administer and enforce state laws, rules, or regulations pertaining to collecting, protecting, and maintaining HIV surveillance data are eligible to apply under this announcement. All of these health departments were eligible to conduct core surveillance activities under PS08 802 (FY2008 FY2012).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This funding opportunity is a CDC cooperative agreement supplement tied to the existing HIV/AIDS Surveillance program (FOA PS08-802). Its main goal is to help currently funded state and local health departments strengthen their HIV surveillance capacity by adding one or both optional "enhanced" activities on top of core surveillance work. In practical terms, the supplement is meant to improve the completeness, usefulness, and actionability of surveillance data so jurisdictions can better track new diagnoses, monitor care outcomes, and target prevention and service efforts.
The supplement offers two distinct activity tracks. Activity I focuses on laboratory reporting. Under this option, funded jurisdictions are expected to improve the reporting of HIV-related laboratory test results coming from both private and public laboratories, with special emphasis on Western Blot confirmatory results, CD4 T-lymphocyte test results, and viral load test results. The scope can also extend to strengthening the reporting of other HIV tests such as screening assays, additional confirmatory tests, and viral resistance testing. The public health payoff CDC is aiming for is a stronger ability to measure and evaluate testing initiatives by using lab data to understand how many people are newly diagnosed, the characteristics of people newly testing positive, and whether individuals are being linked to care and staying in care over time. In other words, better lab reporting is intended to tighten the connection between surveillance and real-world care continuum monitoring.
Activity II centers on geocoding and the use of spatial data. Under this option, jurisdictions enhance their ability to capture, store, analyze, and display location-based information tied to HIV surveillance records. By geocoding addresses or other location indicators, health departments can link HIV surveillance data to other data sources and build a clearer picture of social determinants of health that may be influencing HIV outcomes in affected communities. The announcement highlights key applications such as monitoring and analyzing community viral load and stage of disease at diagnosis, which can help reveal where late diagnoses or uncontrolled viral load are concentrated. This spatial view is also intended to support analysis of access to and utilization of HIV care services, identification of unmet need, and more strategic placement and mapping of testing sites relative to where need is greatest.
Administratively, this is a discretionary funding opportunity using a cooperative agreement structure, meaning CDC anticipates substantial involvement and collaboration with awardees rather than a hands-off grant. The funding opportunity number is CDC RFA PS08-8020401SUPP11, and it is listed under CFDA 93.944 (HIV/AIDS Surveillance). CDC expected to make about 65 awards, with an estimated total funding amount of $17.7 million. Individual awards range from a floor of $15,000 to a ceiling of $400,000, and there is no cost sharing or matching requirement.
Eligibility is narrow and intentionally restricted. Only existing grantees funded under FOA PS08-802 are allowed to apply, which includes state health departments and a defined set of independently funded local health departments (Chicago, Houston, Los Angeles, New York City, the City of Philadelphia, and San Francisco), along with the District of Columbia, specified territorial health departments (Puerto Rico and the U.S. Virgin Islands), and Pacific Island jurisdictions (American Samoa, Guam, Marshall Islands, Palau, the Commonwealth of the Northern Mariana Islands, and the Federated States of Micronesia). The rationale for limiting competition is to maintain a comprehensive, nationwide HIV surveillance system and to ensure applicants are the agencies legally responsible for collecting, protecting, and maintaining HIV surveillance data under applicable laws and regulations.
Key dates show this was posted May 6, 2011, created May 31, 2011, originally due June 6, 2011, and later extended to a current closing date of June 20, 2011, with an archive date of July 20, 2011. The administering agency is the Centers for Disease Control and Prevention, and technical assistance for accessing the full announcement was routed through the CDC Procurement and Grants Office Technical Information Management Section (TIMS).
Frequently Asked Questions (FAQs)
What is this funding opportunity?
This opportunity is a CDC cooperative agreement supplement tied to the existing HIV/AIDS Surveillance program under FOA PS08-802. It is intended to strengthen HIV surveillance capacity by funding one or both optional "enhanced" activities in addition to core surveillance work.
What is the main purpose of the supplement?
The supplement is designed to improve the completeness, usefulness, and actionability of HIV surveillance data so jurisdictions can better track new diagnoses, monitor care outcomes, and target prevention and service efforts.
What is the funding opportunity number and CFDA listing?
The funding opportunity number is CDC RFA PS08-8020401SUPP11. It is listed under CFDA 93.944 (HIV/AIDS Surveillance).
What type of award is this?
This is a discretionary funding opportunity using a cooperative agreement structure. That means CDC anticipates substantial involvement and collaboration with awardees, rather than a hands-off grant relationship.
How many awards does CDC expect to make and what is the total funding?
CDC expected to make about 65 awards, with an estimated total funding amount of $17.7 million.
What is the expected award size?
Individual awards range from a floor of $15,000 to a ceiling of $400,000.
Is there a cost sharing or matching requirement?
No. There is no cost sharing or matching requirement stated for this supplement.
Who is eligible to apply?
Eligibility is limited to existing grantees funded under FOA PS08-802. This includes state health departments and a defined set of independently funded local health departments (Chicago, Houston, Los Angeles, New York City, the City of Philadelphia, and San Francisco), along with the District of Columbia, specified territorial health departments (Puerto Rico and the U.S. Virgin Islands), and Pacific Island jurisdictions (American Samoa, Guam, Marshall Islands, Palau, the Commonwealth of the Northern Mariana Islands, and the Federated States of Micronesia).
Can organizations that are not currently funded under PS08-802 apply?
No. Only existing PS08-802-funded grantees are allowed to apply for this supplement.
Why is eligibility so restricted?
The competition is limited to maintain a comprehensive, nationwide HIV surveillance system and to ensure that applicants are the agencies legally responsible for collecting, protecting, and maintaining HIV surveillance data under applicable laws and regulations.
What activities can be funded under this supplement?
The supplement offers two distinct activity tracks: (1) Activity I: Laboratory Reporting, and (2) Activity II: Geocoding and the use of spatial data. Jurisdictions may add one or both activities on top of core surveillance work.
What is Activity I (Laboratory Reporting)?
Activity I focuses on improving the reporting of HIV-related laboratory test results from both private and public laboratories. The emphasis includes Western Blot confirmatory results, CD4 T-lymphocyte test results, and viral load test results.
Does Activity I allow improving reporting for other HIV tests beyond the emphasized ones?
Yes. The scope can also extend to strengthening the reporting of other HIV tests such as screening assays, additional confirmatory tests, and viral resistance testing.
What is CDC trying to achieve through improved laboratory reporting?
CDC is aiming to strengthen the ability to measure and evaluate testing initiatives by using lab data to understand how many people are newly diagnosed, the characteristics of people newly testing positive, and whether individuals are being linked to care and staying in care over time. The broader intent is to tighten the connection between surveillance and care continuum monitoring.
What is Activity II (Geocoding and Spatial Data)?
Activity II supports enhancements to capture, store, analyze, and display location-based information tied to HIV surveillance records. This includes geocoding addresses or other location indicators to support spatial analysis.
How is geocoding expected to improve HIV surveillance and response?
By enabling jurisdictions to link HIV surveillance data to other data sources, geocoding can help build a clearer picture of social determinants of health influencing HIV outcomes. The announcement highlights uses such as monitoring and analyzing community viral load and stage of disease at diagnosis, identifying where late diagnoses or uncontrolled viral load are concentrated, and supporting analysis of access to and utilization of HIV care services.
What planning or targeting decisions can Activity II support?
Activity II is intended to support identification of unmet need and more strategic placement and mapping of testing sites relative to where need is greatest.
Is this supplement intended to replace core HIV surveillance work?
No. The supplement is intended to add optional enhanced activities on top of existing core surveillance work supported under PS08-802.
Who is the administering agency?
The administering agency is the Centers for Disease Control and Prevention (CDC).
What were the key dates for this opportunity?
It was posted May 6, 2011, created May 31, 2011, originally due June 6, 2011, and later extended to a closing date of June 20, 2011. The archive date is July 20, 2011.
Where could applicants get technical assistance for accessing the full announcement?
Technical assistance for accessing the full announcement was routed through the CDC Procurement and Grants Office Technical Information Management Section (TIMS).
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: International Visitor Leadership Program Assistance Award
Previous opportunity: Subsidy Child Care Program
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA PS08 8020401SUPP11
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA PS08 8020401SUPP11) also looked into and applied for these:
| Funding Opportunity |
|---|
| MCHB State Systems Development Initiative Grant Program Apply for HRSA 12 003 Funding Number: HRSA 12 003 Agency: Health Resources and Services Administration Category: Health Funding Amount: $100,000 |
| HIV Early Intervention Services (EIS) Program Existing Geographic Service Areas (EISEGA) Apply for HRSA 12 014 Funding Number: HRSA 12 014 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Combating Autism Act Initiative (CAAI) National Interdisciplinary Training Resource Center Apply for HRSA 11 135 Funding Number: HRSA 11 135 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Virtual Reality Technologies for Research and Education in Obesity and Diabetes (R41/R42) Apply for RFA HL 12 024 Funding Number: RFA HL 12 024 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Virtual Reality Technologies for Research and Education in Obesity and Diabetes (R43/R44) Apply for RFA HL 12 020 Funding Number: RFA HL 12 020 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| AIDS Education and Training Centers Telehealth Training Centers Apply for HRSA 11 172 Funding Number: HRSA 11 172 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Children s Hospitals Graduate Medical Education Payment Program (CHGME Payment Program) Apply for HRSA 12 007 Funding Number: HRSA 12 007 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Developing and Disseminating Targeted Immunization Materials Apply for CDC RFA IP11 1106 Funding Number: CDC RFA IP11 1106 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $350,000 |
| Public Prevention Health Fund Community Transformation Grant Apply for CDC RFA DP11 1103PPHF11 Funding Number: CDC RFA DP11 1103PPHF11 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| FY11 Announcement of the Anticipated Availability of Funds for Embryo Donation and/or Adoption Cooperative Agreement Projects Apply for PA EAA 11 002 Funding Number: PA EAA 11 002 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $500,000 |
| FY11 Eliminating Lupus Health Disparities Initiative (ELHDI) Apply for MP MPC 11 001 Funding Number: MP MPC 11 001 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $1,000,000 |
| Immunization Strengthening through Measles Control and Related Childhood Morbidity/Mortality Reduction from Vaccine Preventable Diseases Apply for CDC RFA IP11 1105 Funding Number: CDC RFA IP11 1105 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Grants to Support the Hispanic Health Services Research Grant Program Apply for CMS 1H0 11 001 Funding Number: CMS 1H0 11 001 Agency: Centers for Medicare Medicaid Services Category: Health Funding Amount: $100,000 |
| Grants to Support the Historically Black Colleges and Universities Health Services Apply for CMS 1I0 11 001 Funding Number: CMS 1I0 11 001 Agency: Centers for Medicare Medicaid Services Category: Health Funding Amount: $100,000 |
| NIA Limited Competition Renewals of, and Revisions to, Existing Cooperative Agreement Awards (U01) Apply for PAR 11 213 Funding Number: PAR 11 213 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| A Multimedia project to promote child well being, early childhood development research, and violence prevention Apply for CDC RFA CE11 1105 Funding Number: CDC RFA CE11 1105 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $300,000 |
| Expanding HIV Training into Graduate Medical Education Apply for HRSA 11 171 Funding Number: HRSA 11 171 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Blood Safety Surveillance among People with Blood Disorders Apply for CDC RFA DD11 1108 Funding Number: CDC RFA DD11 1108 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $200,000 |
| NIDCD Research On Hearing Health Care (R21/R33) Apply for RFA DC 12 003 Funding Number: RFA DC 12 003 Agency: National Institutes of Health Category: Health Funding Amount: $275,000 |
| Craniofacial Malformations Information for Affected Families, Health Care Providers, and School Professionals Apply for CDC RFA DD11 1105 Funding Number: CDC RFA DD11 1105 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $300,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA PS08 8020401SUPP11", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.